v3.25.2
Stockholders’ Equity
 12 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Stockholders’ Equity
Note 8 – Stockholders’ Equity
2025
Common Stock		2024
Common Stock		2025
Amount		2024
Amount
Common stock issued and outstanding, par value16,717,289 13,915,524 $16,717 $13,915 
Movement in Common Stock
DateTamboran Common StockIssue PriceDetailsNet Proceeds
Balance as of July 1, 20237,080,054$252,177,665 
Capital raise
July and August 20231,503,309$0.12 $36,151,220 
Capital raise
December 20231,274,525$0.11 27,660,258 
Capital raise
January 2024443,548$0.11 9,328,083 
Capital raise
June 20243,125,000$24.00 75,000,000 
Conversion of 5.5% Convertible Senior Note
June 2024489,088$24.00 11,738,112 
Less: Transaction costs
(15,131,161)144,746,512 
Balance as of July 1, 2024
13,915,524396,924,177 
Capital raiseJuly 2024308,750$24.00 7,410,000 
Issuance of common stock as Checkerboard feeNovember 2024312,500$19.04 5,950,000 
Capital raiseMay 20252,180,515$17.74 38,682,336 
52,042,336 
Shares to be issued5,722,374 
Less: Transaction costs(4,251,666)53,513,044 
Balance as of June 30, 2025$16,717,289 $450,437,221 
Holders of common stock of the Company are entitled to participate in any dividends declared and any proceeds attributable to common stockholders should the Company be wound up, in proportions that consider both the number of shares held and the extent to which those common stock are paid up. Holders of shares of the Company’s common stock are entitled to one vote for each share of record on all matters on which stockholders are entitled to vote generally. The holders of the CDIs are the beneficial owners of, and generally have the same voting, economic and other rights as holders of our common stock, although they are required to exercise those rights indirectly through a depositary who holds shares of common stock.
No dividends have been declared or paid by the Company through June 30, 2025 and 2024.

July 2024 Greenshoe Option
Subsequent to the IPO in June 2024, the underwriters exercised the greenshoe option granted to them to purchase additional shares of common stock of the Company. Under this option, underwriters purchased a total of 308,750 shares of common stock of the Company on July 30, 2024.
November 2024
At the time of the IPO, DWE agreed to waive the $7,500,000 payment obligation in respect of the Checkerboard Strategy provided that Tamboran issue to DWE, or its nominee, 312,500 shares of common stock. The number of shares to be issued to satisfy the obligation was calculated as $7,500,000 divided by the IPO share price of $24.00 The issuance of these shares in satisfaction of the obligation was subject to shareholder approval.
Shareholder approval took place at the Annual General Meeting on November 4, 2024, which was determined to be the grant date for the purpose of valuing the common stock. From the time of the IPO in June 2024 to shareholder approval in November 2024, the fair market value of the shares decreased from $24.00 to $19.04, while the number of shares to be issued remained the same. The issuance of these shares completed the satisfaction of the above obligation in respect of the Checkerboard Strategy (the “Checkerboard fee”) (Refer Note 3).
May 2025
On May 12, 2025, the Company entered into subscription agreements (the “Subscription Agreements”) with certain investors (the “Investors”), pursuant to which, among other things, the Investors agreed to subscribe for and purchase from the Company, and the Company agreed to issue and sell to the Investors, an aggregate of 3,121,244 newly issued shares of the Company’s common stock, par value $0.001, for an aggregate purchase price of $55,370,869, on the terms and subject to the conditions set forth therein (the “Offering”). Of the Offering, $38,682,336 (“First Tranche”) was closed on May 16, 2025, with the issuance of 2,180,515 shares of common stock for $17.74 per share.

Common Stock to be Issued

Of the Offering, the closing of the remaining $16,688,532 (“Second Tranche”) is subject to approval by Tamboran’s shareholders and the satisfaction of other customary closing conditions. On May 16, 2025, the Company received $5,722,374 of gross proceeds in advance from certain investors in respect of Second Tranche, which is held as restricted cash until this issuance of shares is complete.

As of June 30, 2025 there were 940,729 shares of common stock to be issued in Second Tranche, pursuant to the Subscription Agreements for which the Company has received the Proceeds in advance.

As of June 30, 2025, the Company incurred $768,275 in deferred offering costs which is included in “Prepaid expenses and other assets” on the Group's Consolidated Statements of Cash Flows.